Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that major-market sales of antiretroviral agents for HIV will decline slightly over the next decade, from an estimated $13.3 billion in 2011 to $12.9 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
120360
Sales of antiretroviral agents for HIV will decline slightly over the next decade
105600
MedImmune cutting jobs in California
128708
Bananas could prevent spread of HIV
8589
$10.4 billion increase in NIH funding could increase HIV/AIDS research
19593
Drug plans not sustainable
167863
Survival rate of HIV patients continues to improve
39697
Myths around AIDS still abound
11644
How does HIV affect the brain?
155316
Drug trafficking through West Africa decreases dramatically.
32522
Cancer drugs sold off by trust in short supply
116469
385 new HIV cases reported in first 10 months of this year
151825
Toward stem cell pharmacies
139333
Very early antiretroviral treatment limits the size of HIV reservoir
119280
Cost of treating heart disease and stroke to triple
143992
African wind turbine market earned revenues of over us$148.4 million in 2008
88710
Nanoviricides completes a number of financing activities
40508
The ovarian cancer drug market will more than triple over the next decade, increasing from $460 million in 2011 to $1.4 billion in 2021